Bioabsorbable Stent Market to Cross USD 2.4 Billion by 2031 as Demand for Temporary Cardiovascular Solutions Rises
[Zurich, 24 July 2025] – The global bioabsorbable stent market is expected to grow from USD 1.08 billion in 2024 to USD 2.45 billion by 2031, with a compound annual growth rate (CAGR) of 12.6%, according to Clearview Market Insights (CVMI). The increase is driven by rising demand for non-permanent cardiovascular implants and continuous innovation in polymer materials and scaffold design.
Request Sample: https://clearviewmarketinsights.com/report-details/global-bioabsorbable-stent-market/
“Bioabsorbable stents are redefining the future of coronary intervention by providing temporary scaffolding while reducing long-term risks,” said Dr. Julien Moreau, Cardiovascular Devices Lead at CVMI. “The technology is now overcoming early challenges with better outcomes and safety profiles.”
While North America lags slightly in regulatory momentum, Europe and Asia-Pacific are advancing clinical adoption. Major market players like Abbott, BIOTRONIK, Reva Medical, and Amaranth are investing in clinical trials and innovative materials.
Recent developments such as radiopaque scaffolds, optimized drug coatings, and staged resorption models are gaining attention for their ability to enhance vascular healing and procedural precision. NGO-led pilot programs are also boosting early-stage deployments in underserved cardiac populations.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian